SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies wins FICCI Healthcare Award 2023

01 Nov 2023 Evaluate

Venus Remedies has won FICCI Healthcare Award 2023 in the esteemed ‘Excellence in Patient Safety and Care’ category. The award recognizes the company’s groundbreaking 'Organ-on-a-Chip' research model, a first-of-its-kind development in India, showcased at the Venus Medicine Research Centre (VMRC), the organization’s R&D wing. The path to this laudable achievement for Venus was marked by an intensive evaluation process, an exemplar of the rigorous standards upheld by FICCI to identify and honour meritorious contributions in patient care and safety.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

1038.80 -3.55 (-0.34%)
20-Apr-2026 14:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1233.00
Cipla 1232.25
Zydus Lifesciences 937.65
Lupin 2328.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×